Randomized, controlled phase I/II, trial of combination therapy with delavirdine (U-90152S) and conventional nucleosides in human immunodeficiency virus type 1-infected patients.

Lignende værker

• Idiopathic CD4(+) lymphocytopenia: natural history and prognostic factors
  af: Zonios, Dimitrios I., et al.
  Udgivet: (2008)
• Delavirdine Susceptibilities and Associated Reverse Transcriptase Mutations in Human Immunodeficiency Virus Type 1 Isolates from Patients in a Phase I/II Trial of Delavirdine Monotherapy (ACTG 260)
  af: Demeter, L. M., et al.
  Udgivet: (2000)
• Effect of fluconazole on the steady-state pharmacokinetics of delavirdine in human immunodeficiency virus-positive patients.
  af: Borin, M T, et al.
  Udgivet: (1997)
• Single-dose pharmacokinetics of delavirdine mesylate and didanosine in patients with human immunodeficiency virus infection.
  af: Morse, G D, et al.
  Udgivet: (1997)
• Clarithromycin lowers plasma zidovudine levels in persons with human immunodeficiency virus infection.
  af: Polis, M A, et al.
  Udgivet: (1997)